Although pre-exposure prophylaxis (PrEP)—the use of antiretroviral drugs by non-infected
people to prevent the acquisition of HIV—is a promising preventive option, important public …

Pre-exposure prophylaxis (PrEP) is a potent and underutilized HIV prevention tool. In this
paper we review the state of knowledge regarding PrEP implementation for men who have …

Summary Background In the UK, HIV incidence among men who have sex with men (MSM)
has remained high for several years, despite widespread use of antiretroviral therapy and …

We aim to provide evidence-based guidance on best clinical practice in the provision,
monitoring and support of pre-exposure prophylaxis (PrEP) for the prevention of HIV …

Introduction: In settings where both daily and event-driven pre-exposure prophylaxis (PrEP)
are offered to men who have sex with men (MSM), a clear understanding of the motives to …

Abstract Introduction The Amsterdam Pr EP project is a prospective, open‐label
demonstration study at a large sexually transmitted infection (STI) clinic. We examined the …

Abstract Background The Global Burden of Disease, Injuries, and Risk Factors Study (GBD)
has reported that HIV/AIDS continues to take a disproportionate toll on global health …

Human immunodeficiency virus (HIV) sexual transmission among men who have sex with
men (MSM) has increased markedly in Beijing, China in the past decade. Pre-exposure …

Risk of HIV infection is high in Chinese MSM, with an annual HIV incidence ranging from
3.41 to 13.7/100 person-years. Tenofovir-based PrEP is effective in preventing HIV …

Introduction Event‐driven pre‐exposure prophylaxis (edPrEP) with oral tenofovir disoproxil
fumarate (TDF)/emtricitabine (FTC) is highly effective for preventing HIV acquisition in men …